Stewart Fisher C4 Therapeutics, Inc. (CCCC) insider trading activity

Stewart Fisher is Chief Scientific Officer of C4 Therapeutics, Inc.. Currently has a direct ownership of 129,121 shares of CCCC, which is worth approximately $752,775. The most recent transaction as insider was on Feb 14, 2024, when has been sold 27,300 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 129K

0% 3M change

24.06% 12M change

Total Value Held $752,775

Stewart Fisher Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Feb 14 2024	BUY Grant, award, or other acquisition	-	27,300 Added 17.45%	129,121 Common Stock
Feb 13 2024	SELL Payment of exercise price or tax liability	$14,725 $6.53 p/Share	2,255 Reduced 2.17%	101,821 Common Stock
Aug 30 2023	SELL Payment of exercise price or tax liability	$1,936 $2.93 p/Share	661 Reduced 0.63%	104,076 Common Stock
Aug 30 2023	BUY Exercise of conversion of derivative security	-	2,250 Added 2.1%	104,737 Common Stock
Feb 13 2023	BUY Grant, award, or other acquisition	-	26,000 Added 20.24%	102,487 Common Stock
Jan 30 2023	SELL Payment of exercise price or tax liability	$10,121 $7.78 p/Share	1,301 Reduced 1.67%	76,487 Common Stock
Jan 30 2023	BUY Exercise of conversion of derivative security	-	3,750 Added 4.6%	77,788 Common Stock
May 25 2022	BUY Exercise of conversion of derivative security	-	3,750 Added 4.75%	75,140 Common Stock
Apr 12 2022	BUY Exercise of conversion of derivative security	$122,165 $4.35 p/Share	28,084 Added 28.23%	71,390 Common Stock
Dec 08 2021	BUY Exercise of conversion of derivative security	$74,023 $3.6 p/Share	20,562 Added 32.19%	43,306 Common Stock
Aug 03 2021	SELL Open market or private sale	$767,736 $45.01 p/Share	17,057 Reduced 42.86%	22,744 Common Stock
Aug 02 2021	SELL Open market or private sale	$814,680 $45.0 p/Share	18,104 Reduced 31.27%	39,801 Common Stock
Jul 29 2021	SELL Open market or private sale	$2,259,495 $45.0 p/Share	50,211 Reduced 46.44%	57,905 Common Stock
Feb 03 2021	BUY Exercise of conversion of derivative security	$24,153 $2.91 p/Share	8,300 Added 7.13%	108,116 Common Stock
Dec 11 2020	BUY Exercise of conversion of derivative security	$42,032 $2.91 p/Share	14,444 Added 12.64%	99,816 Common Stock

Stewart Fisher

Chief Scientific Officer

Watertown, MA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CCCC shares.

Notify only if

Value

Insider Trading

Get notified when an C4 Therapeutics, Inc. insider buys or sells CCCC shares.

Notify only if

Operation

Value

Type

News

Receive news related to C4 Therapeutics, Inc.

Track Activities on CCCC

Account